BioCentury
ARTICLE | Clinical News

CYFRA 21-1 EIA assay regulatory update

June 6, 2011 7:00 AM UTC

Fujirebio's Fujirebio Diagnostics Inc. unit received 510(k) clearance from FDA for its CYFRA 21-1 EIA assay to monitor disease progression in lung cancer patients. The biomarker assay kit that detects...